Clinical Trial Update: VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Velcade-Thalidomide-Dexamethasone (VTD) versus Thalidomide-Dexamethasone (TD) in double autotransplantation for untreated multiple myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Michele Cavo | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN